colitis, ulcerative
Showing 26 - 50 of 157
Ustekinumab in Participants Suffering From Inflammatory Bowel
Recruiting
- Crohn Disease
- Colitis, Ulcerative
-
Vandoeuvre les Nancy, FranceCHU de Nancy - Hôpital de Brabois
Aug 17, 2022
Real World Data on Vedolizumab Concentration and Outcomes in
Enrolling by invitation
- Inflammatory Bowel Diseases
- +2 more
-
Osijek, CroatiaKlinički bolnički centar Osijek (University Hospital Center Osij
Aug 15, 2022
Crohn Disease, Colitis, Ulcerative Trial (TEV-48574, Placebo)
Not yet recruiting
- Crohn Disease
- Colitis, Ulcerative
- TEV-48574
- Placebo
- (no location specified)
Aug 11, 2022
Colitis, Ulcerative Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)
Not yet recruiting
- Colitis, Ulcerative
- Guselkumab
- +3 more
-
Arcadia, California
- +236 more
Jul 14, 2022
Kynteles Injection in Moderate to Severe Ulcerative Colitis or
Recruiting
- Inflammatory Bowel Diseases
- +2 more
-
Bucheon, Korea, Republic of
- +49 more
Jun 29, 2022
Colitis, Ulcerative, Obesity Trial in La Jolla (Phentermine-Topiramate, Placebo)
Recruiting
- Colitis, Ulcerative
- Obesity
- Phentermine-Topiramate
- Placebo
-
La Jolla, CaliforniaUniversity of California San Diego
Jun 9, 2022
Administration Choices of Vedolizumab and Outcomes for
Recruiting
- Inflammatory Bowel Diseases
- +2 more
-
Osijek, Croatia
- +7 more
May 31, 2022
Moderate to Severe Inflammatory Bowel Disease, Including
Completed
- Inflammatory Bowel Diseases
- +2 more
-
Torreon, Coahuila, Mexico
- +11 more
May 26, 2022
IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Infliximab
- Adalimumab
-
Gent, Belgium
- +6 more
May 17, 2022
Colitis, Ulcerative Trial in Worldwide (Treatment Algorithm A, Treatment Algorithm B, Treatment Algorithm C)
Recruiting
- Colitis, Ulcerative
- Treatment Algorithm A
- +2 more
-
Ypsilanti, Michigan
- +44 more
Apr 4, 2022
Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative
Completed
- Colitis, Ulcerative
- No Intervention
-
Ansan-si, Korea, Republic of
- +14 more
Mar 30, 2022
IBD, Colitis, Ulcerative, Magnesium Deficiency Trial in Aarhus N (Magnesium acetate mixture (30 mmol/ml), High-protein diet (2
Recruiting
- Inflammatory Bowel Diseases
- +4 more
- Magnesium acetate mixture (30 mmol/ml)
- High-protein diet (2 g/kg/day)
-
Aarhus N, DenmarkAarhus University Hospital
Feb 27, 2022
Colitis, Ulcerative Trial in Denver (Creatine monohydrate, Placebo)
Not yet recruiting
- Colitis, Ulcerative
- Creatine monohydrate
- Placebo
-
Denver, ColoradoUniversity of Colorado Hospital
Feb 18, 2022
Colitis, Ulcerative Trial in Worldwide (Vedolizumab)
Recruiting
- Colitis, Ulcerative
-
Minneapolis, MinnesotaMNGI Digestive Health, PA
Jan 21, 2022
Healthy, Colitis, Ulcerative Trial in Berlin (JNJ-66525433, Placebo)
Terminated
- Healthy
- Colitis, Ulcerative
- JNJ-66525433
- Placebo
-
Berlin, GermanyCharité Research Organisation GmbH
Dec 29, 2021
Colitis, Ulcerative Trial in Worldwide (Guselkumab Dose 1, Guselkumab Dose 2, Golimumab Dose 1)
Completed
- Colitis, Ulcerative
- Guselkumab Dose 1
- +4 more
-
San Diego, California
- +81 more
Dec 30, 2021
How Vedolizumab is Given and Outcomes for Inflammatory Bowel
Recruiting
- Inflammatory Bowel Diseases
- +2 more
-
Antwerpen, Belgium
- +9 more
Dec 7, 2021
Ulcerative Colitis or Crohn's Disease Receiving Vedolizumab in
Recruiting
- Inflammatory Bowel Diseases
- +2 more
-
St. Gallen, Saint Gallen, Switzerland
- +5 more
Nov 23, 2021
Colitis, Ulcerative Trial in Saint-Etienne (rectosigmoidoscopy, biopsies, blood sample)
Recruiting
- Colitis, Ulcerative
- rectosigmoidoscopy
- +2 more
-
Saint-Etienne, FranceCHU Saint-Etienne
Nov 16, 2021